Document is current
Any future updates will be listed below
-
Authors
Sailer, Clara Odilia https://orcid.org/0000-0001-6439-8191
Refardt, Julie https://orcid.org/0000-0002-3040-4685
Blum, Claudine Angela https://orcid.org/0000-0003-0487-5587
Schnyder, Ingeborg
Molina-Tijeras, Jose Alberto
Fenske, Wiebke
Christ-Crain, Mirjam https://orcid.org/0000-0002-6336-0965
-
Funding
Funding for this research was provided by:
Swiss Academy of Medical Sciences and of the G.& J. Bangerter-Rhyner Foundation
Federal Ministry of Education and Research Germany (FKZ: 01EO1501)
Deutsche Forschungsgemeinschaft (DFG) Germany ((AOBJ: 624808))
Swiss National Science Foundation (SNF-162608)
- License Information
-
More Information
Article History
Received: 22 January 2021
Accepted: 26 April 2021
First Online: 12 May 2021
Competing interests
: MCC received speaking honoraria from Thermo Fisher Scientific, the manufacturer of Brahms Copeptin proAVP KRYPTOR and Brahms CT-proAVP LIA assay. The other authors declare no competing interests.
